Immunostep
1 known investors
Find your way into Immunostep
Sign up to see every warm intro you have to Immunostep
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immunostep team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImmunoStep produces monoclonal antibodies for research use, including recombinant antibodies that target specific T-cell receptors for flow cytometry applications in immunology research.
Investors · 1
In the news
Frequently asked questions
- What does Immunostep do?
- ImmunoStep produces monoclonal antibodies for research use, including recombinant antibodies that target specific T-cell receptors for flow cytometry applications in immunology research.
- Who are Immunostep's investors?
- Immunostep's investors include Unirisco Galicia.